Literature DB >> 1520606

New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.

Z C Han1, S Bellucci, H Y Wan, J P Caen.   

Abstract

Effects of cytokines on murine megakaryocyte (MK) colony formation from either unfractionated marrow cells or purified early haematopoietic cells were studied. Recombinant interleukin-3 (IL3), interleukin-6 (IL6), granulocyte-macrophage colony-stimulating factor (GM-CSF), erythropoietin (Epo) and acidic and basic fibroblast growth factor (aFGF and bFGF) each was able to stimulate MK colony growth although they varied somewhat in their potential. IL6 and FGFs, in addition to their effect on MK colony growth, increased the size of individual MK. The combination of IL3 with IL6 or FGF resulted in an additive action. Monoclonal anti-IL6 antibody completely neutralized the activity of mouse IL6 and FGFs but had no effect on human IL6, mouse IL3 and GM-CSF. When using purified lineage negative marrow cells, only IL3 and IL6 promoted MK colony formation. Transforming growth factor beta 1 (TGF-beta 1) at 10-200 pg/ml selectively inhibited IL3-induced MK colony formation, and at 0.2-0.5 ng/ml it still had no obvious effect on the activity of IL6 or GM-CSF but caused an inhibition of FGF-induced MK colony formation. These data suggest that differential mechanisms are involved in the regulation of megakaryocytopoiesis by IL3, IL6, FGFs and GM-CSF, and that TGF-beta 1 negatively regulates MK development mainly by interfering with the action of IL3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520606     DOI: 10.1111/j.1365-2141.1992.tb08161.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

2.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

3.  Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells.

Authors:  Yong Jun Liu; Shi Hong Lu; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

Review 4.  Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

Authors:  M C Le Bousse-Kerdilès; M C Martyré
Journal:  Springer Semin Immunopathol       Date:  1999

5.  Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells.

Authors:  M Yang; K Li; A C Lam; P M Yuen; T F Fok; C N Chesterman; B H Chong
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

6.  A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings.

Authors:  H T Hassan; A R Hanauske; E Lux; H D Kleine; M Freund
Journal:  Int J Exp Pathol       Date:  1995-10       Impact factor: 1.925

7.  Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.

Authors:  C N Metz; G Brunner; N H Choi-Muira; H Nguyen; J Gabrilove; I W Caras; N Altszuler; D B Rifkin; E L Wilson; M A Davitz
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.